Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Balchem Corp Market Cap
The Balchem Corp (BCPC) share price is expected to increase by 8.52% over the next year. This is based on calculating the average 12-month share price estimate provided by 2 stock analysts who have covered BCPC. Price targets range from $175 at the low end to $206 at the high end. The current analyst consensus for BCPC is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 2 Wall Street analysts have assigned BCPC 2 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Balchem Corp to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BCPC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of BCPC.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $190 | Maintains | Nov 4, 2024 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $185 | Maintains | Jul 31, 2024 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $170 | Maintains | May 6, 2024 |
HC Wainwright & Co. | Buy | Maintains | Feb 20, 2024 | |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $135 | Maintains | Oct 30, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $165 | Maintains | Jul 31, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $150 | Maintains | Jun 5, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $140 | Maintains | Feb 27, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $152 | Maintains | Nov 7, 2022 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $164 | Maintains | Aug 22, 2022 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $152 | Maintains | May 2, 2022 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $155 | Maintains | Mar 8, 2022 |
Sidoti & Co. | Buy | Upgrade | Feb 22, 2022 | |
HC Wainwright & Co. | Buy | $170 | Maintains | Jan 10, 2022 |
Sidoti & Co. | Neutral | Downgrade | Nov 29, 2021 | |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $160 | Upgrade | Aug 2, 2021 |
| Mark Connelly Stephens & Co. | Equal-Weight | $145 | Downgrade | Aug 2, 2021 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $145 | Maintains | Feb 22, 2021 |
| Mark Connelly Stephens & Co. | Overweight | $140 | Upgrade | Feb 22, 2021 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $126 | Maintains | Aug 4, 2020 |
When did it IPO
1986
Staff Count
1,300
Country
United States
Sector/Industry
Basic Materials/Specialty Chemicals
CEO
Mr. Theodore L. Harris
Market Cap
$5.84B
In 2023, BCPC generated $922.4M in revenue, which was a decrease of -2.11% from the previous year. This can be seen as a signal that BCPC's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Tue, 03 Dec 2024
Sentiment - NEGATIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) and MAG Silver (MAG) have been compared to their sector's performance in 2023. Specific performance metrics were not disclosed in the excerpt.
Why It Matters - Performance comparisons highlight relative strength or weakness, influencing investment decisions and portfolio allocation for Blachem and MAG Silver within their sector.
Thu, 21 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) is identified as a potential option for short-term investors, having passed a trading strategy screen for fundamentally sound stocks.
Why It Matters - Blachem's recent positive screening suggests potential for short-term gains, indicating investor confidence and a favorable price trend in fundamentally strong stocks.
Fri, 15 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) and L.B. Foster (FSTR) have shown performance metrics relative to their sector in 2023, indicating their market standing. Further details on specific performance were not provided.
Why It Matters - Performance comparisons highlight potential investment opportunities or risks, influencing decision-making based on relative strength or weakness in the sector.
Tue, 05 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) has passed the "Recent Price Strength" screen, indicating it may be well-positioned to continue its recent uptrend, making it a potential stock choice for investors.
Why It Matters - Blachem's strong performance and positive screening indicate potential for continued growth, suggesting it may be a solid investment opportunity for capital appreciation.
Fri, 01 Nov 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Balchem Corporation (NASDAQ: BCPC) will present at Baird's 54th Annual Global Industrial Conference on November 13, 2024.
Why It Matters - Balchem's presentation at a prominent conference could signal strategic initiatives or growth prospects, influencing stock performance and investor sentiment.
Fri, 01 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) has received a Zacks Rank #1 (Strong Buy), indicating improved earnings outlook and potential for stock price increase.
Why It Matters - Blachem's upgrade to a Zacks Rank #1 signals strong earnings potential, likely boosting investor confidence and increasing demand for the stock in the short term.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
